Mortality and morbidity among military personnel and civilians during the 1930s and World War II from transmission of hepatitis during yellow fever vaccination: Systematic review

American Journal of Public Health

Volumn 103, Issue 3, 2013, Pages

  Thomas, Roger E ^a   Lorenzetti, Diane L ^a   Spragins, Wendy ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VACCINE;

CUBA; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HISTORY; HUMAN; JAUNDICE; MALE; MILITARY MEDICINE; MORTALITY; PANAMA; REVIEW; SOLDIER; STATISTICS; UNITED STATES; VIRUS HEPATITIS; WAR;

CUBA; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS, VIRAL, HUMAN; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; JAUNDICE; MALE; MILITARY MEDICINE; MILITARY PERSONNEL; PANAMA; UNITED STATES; WORLD WAR II; YELLOW FEVER VACCINE;

MLCS; MLOWN;

EID: 84874056497     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2012.301158     Document Type: Review

References (98)

1. Paul JR, Gardner HT. Viral hepatitis. In: Coates JB Jr, Hoff EC, Hoff PM, eds. Preventive Medicine in World War II. Volume III. Personal Health Measures and Immunization. Washington, DC: Dept of the Army; 1955:411-443.
2. Stock NK, Boschetti N, Herzog C, Appelhans MS, Niedrig M. The phylogeny of yellow fever virus 17D vaccines. Vaccine. 2012;30:989-994.
3. Long AP. Vaccination against yellow fever. In: Coates JB Jr, Hoff EC, Hoff PM, eds. Preventive Medicine in World War II. Volume III. Personal Health Measures and Immunization. Washington, DC: Dept of the Army; 1955:306-313.
4. Surgeon General, United States Army. Jaundice. Circular Letter No. 45, May 13, 1942.
5. Monath TP, Cetron MS, Teuwen DE. Yellow fever vaccine. In: Plotkin SA, OrensteinWA, Offit PA, eds. Vaccines. 5th ed. New York: Elsevier; 2008:chap 36.
6. Gauld RL. Epidemiological field. Studies of infectious hepatitis in the Mediterranean Theater of Operations. VIII. Relation between vaccine jaundice and hepatitis I. Am J Hyg. 1946;43(3): 310-313.
7. Badger TL. Hepatitis following yellow fever vaccination. Proc R Soc Med. 1944;37:456-458.
8. Benjamin JE, Hoyt RC. Disability following postvaccinal (yellow fever) hepatitis. J Am Med Assoc. 1943;128(5): 319-324.
9. De Veer JA, Matzne MJ. Postvaccinal (yellow fever) jaundice: report of fatal case. U S Nav Med Bull. 1944;42:1381-1387.
10. Freeman G. Epidemiology and incubation period of jaundice following yellow fever vaccination. Am J Trop Med Hyg. 1946;26(1):15-32.
11. Hayman JM Jr, Read WA. Some clinical observations on an outbreak of jaundice following yellow fever vaccination. Am J Med Sci. 1945;209:281-296.
12. Sawyer WA, Meyer KF, Eaton MD, Bauer JH, Putnam P, Schwentker FF. Jaundice in Army personnel in theWestern Region of the United States and its relation to vaccination against yellow fever. Part I. Am J Hyg. 1944;39(3):337-430.
13. Turner RH, Snavely JR, Grossman EB, Buchanan RN, Foster SO. Some clinical studies of acute hepatitis occurring in soldiers after inoculation with yellow fever vaccine; with especial consideration of severe attacks. Ann Intern Med. 1944; 20(2):193-218.
14. Walker DW. Some epidemiological aspects of infectious hepatitis in the US Army. Am J Trop Med. 1945;25:75-82.
15. Sawyer WA, Meyer KF, Eaton MD, Bauer JH, Putnam P, Schwentker FF. Jaundice in Army personnel in the Western Region of the United States and its relation to vaccination against yellow fever. Parts II, III & IV. Am J Hyg. 1944;40(1):35-107.
16. Editorial. Jaundice following yellow fever vaccination. JAMA. 1942;119(14): 110.
17. Havens WP Jr. The military importance of viral hepatitis. US Armed Forces Med J. 1952;3(7):1013-1022.
18. MacCallum FO, Bauer DJ. Homologous serum jaundice transmission experiments with human volunteers. Lancet. 1944;243(6298):622-627.
19. McArthur NM. An epidemic of hepatitis. J R Nav Med Serv. 1944;30(1): 18-22.
20. Findlay GM, Martin NH, Mitchell JB. Hepatitis after yellow, fever Inoculation. Relation to infective hepatitis. II. Immunology and epidemiology. Lancet. 1944; 244(6316): 365-370.
21. Findlay GM, MacCallum FO. Note on acute hepatitis and yellow fever immunization. Trans R Soc Trop Med Hyg. 1937;31(3):297-308.
22. Findlay GM, MacCallum FO. Hepatitis and jaundice associated with immunization against certain virus diseases. Proc R Soc Med. 1938;31(7):799-806.
23. Fox JP, Manso C, Penna HA, Pará M. Observations on the occurrence of icterus in Brazil following vaccination against yellow fever. Am J Hyg. 1942;36(1): 68-116.
24. Oliphant JW. Jaundice following administration of human serum. Bull N Y Acad Med. 1944;20(8):429-445.
25. Oliphant JW, Gilliam AG, Larson CL. Jaundice following administration of human serum. Public Health Rep. 1943; 58(33):1233-1242.
26. Wilbur A. Sawyer Papers. Controlling disease during World War II, 1939-1944. Profiles in Science, National Library of Medicine. Available at: http://profiles.nlm.nih.gov/ps/retrieve/Narrative/LW/p-nid/139. Accessed May 28, 2012.
27. Surgeon General, United States Army. Circular Letter No. 95: the outbreak of jaundice in the army. J Am Med Assoc. 1942;126(1):51-53.
28. Martin NA. The discovery of hepatitis A: a military perspective. J R Army Med Corps. 2003;149(2):121-124.
29. Boughton CR. Jaundice and war: viral hepatitis and other causes of jaundice in times of war. Health History. 2002;4(2):41-56.
30. Havens WP Jr. Viral hepatitis. Yale J Biol Med. 1961;34:314-328.
31. Lürman A. Eine ikterusepidemie. Berliner klinische Wochenschrift. January 12, 1885:20-23.
32. Jehn J. Eine icterusepidemie in wahrscheinlichem Zusammenhang mit vorausgegangener revaccination. Deutsche Medizinische Wochenschrift. May 1885;11:339-340, 354-356.
33. Jehn J. Eine icterusepidemie in wahrscheinlichem Zusammenhang mit vorausgegangener revaccination. Deutsche Medizinische Wochenschrift. May 1885;11: 354-356.
34. Flaum A, Malmros H, Persson E. Eine nosocomiale ikterus-epidemie. Acta Med Scand. 1926;(suppl 16): 544-553.
35. Theiler A. Acute liver-atrophy and parenchymatous hepatitis in horses. In: The Fifth and Sixth Reports of the Director of Veterinary Research. Department of Agriculture, Division of Veterinary Research. (Pretoria: Union of South Africa Government Printing and Stationery Office; 1919):7-164.
36. Marsh H. Losses of undetermined cause following an outbreak of equine encephalomyelitis. J Am Vet Med Assoc. 1937;91:88-93.
37. Soper FL, Smith HH. Yellow fever vaccination with cultivated virus and hyperimmune serum. Am J Trop Med. 1938;18:111-134.
38. Findlay GM. Infective hepatitis and catarrhal jaundice. J R Army Med Corps. 1940;74:72-79.
39. MacNalty AS. Acute infectious jaundice and administration of measles serum. In: Great Britain, Ministry of Health, on the State of the Public Health. Annual Report of the Chief Medical Officer of the Ministry of Health for the Year 1937. Publication No. 42. London, UK: His Majesty's Stationery Office; 1938.
40. Propert SA. Hepatitis after prophylactic serum. BMJ. 1938;2:677-678.
41. Cockayne EA. Catarrhal jaundice, sporadic and epidemic and its relation to acute yellow atrophy of the liver. Q JMed. 1912;os6(1):1-29.
42. Cockayne EA. Epidemic catarrhal jaundice. Lancet. 1914;184(4743): 218-220.
43. Willcox WH. The epidemic jaundice of campaigns. BMJ. 1916;1:297-300.
44. Pickles WM. Epidemiology in Country Practice. London, UK: John Wright & Sons; 1939.
45. McCullough D. The Path Between The Seas: The Creation of the Panama Canal 1870-1914. New York, NY: Simon and Schuster; 1977:413.
46. Parker M. Panama Fever. New York, NY: Doubleday; 2007.
47. Craddock WL. The achievements of William Crawford Gorgas. Mil Med. 1997;162(5):325-327.
48. Reed W, Carroll J, Agramonte A, Lazear JW. The etiology of yellow fever-a preliminary note. Public Health Papers and Reports. 1900;26:37-53.
49. The United States Yellow Fever Commission (1900-1901). Available at: http://yellowfever.lib.virginiaedu/reed/cmmissioon.html. Accessed July 18, 2012.
50. Maurer N, Yu C. The Big Ditch. How America Took, Built, Ran, and Ultimately Gave Away the Panama Canal. Princeton, NJ: Princeton University Press; 2011.
51. Coox AD. Nomonohan. Japan Against Russia, 1939. Stanford, CA: Stanford University Press; 1985.
52. Viale CR. Prelude to war: Japan's goals and strategy in World War II. US Army Command and General Staff College, Fort Leavenworth, Kansas, School of Advanced Military Studies. May 17, 1988. Available at: http://www.dtic.mil/cgi- bin/GetTRDoc?Location=U2&doc=GetTRDoc.pdf&AD=ADA202272. Accessed July 9, 2012.
53. Coakley RW. World War II against Japan. In: American Military History. Army Historical Series. Washington, DC: Office of the Chief of Military History, United States Army; 1989:501-528.
54. Hoyt EP. Yamamoto. The Man Who Planned Pearl Harbor. New York, NY: McGraw-Hill Publishing Company; 1990.
55. Hiroyuki A. The Reluctant Admiral: Yamamoto and the Imperial Navy, trans. J. Bester. Tokyo, Japan: Kodansha International Ltd; 1979.
56. Sawyer WA, Whitman L. Yellow fever immunity survey of North, East and South Africa. Trans R Soc Trop Med Hyg. 1936;29:397-412.
57. Sawyer WA, Bauer JH, Whitman L. The distribution of yellow fever immunity in North America, Central America, The West Indies, Europe, Asia and Australia, with special reference to the specificity of protection tests. Am J Trop Med. 1937;17:137-161.
58. Findlay GM, Martin NH. Jaundice following yellow-fever immunization. Transmission by intranasal instillation. Lancet. 1943;241(6248):678-680.
59. Homologous serum jaundice: memorandum prepared by Medical Officers of the Ministry of Health. Lancet. 1943;1: 83-88.
60. Beattie J, Marshall J. The aetiology of post-arsphenamine jaundice. BMJ. 1944;1(4346):547-550.
61. War Office. Jaundice Associated With Syphilis Treatment and With Blood Transfusion. Statistical Report on the Health of the Army 1943-1945. London, UK: HMSO; 1948.
62. Havens WP Jr. Infectious hepatitis. Medicine. 1948;27(3):279-326.
63. Paul JR, Gardner HT. Epidemiologic aspects of hepatitis in US troops in Germany 1946-1950. Am J Med. 1950; 5:565-580.
64. Paul Jr. Viral hepatitis preventive and clinical aspects. Med Bull U S Army Eur Command Med Div. 1951;8(10): 445-448.
65. Kaufmann GG, Sborov VM, Havens WP Jr. Outbreak of infectious hepatitis, presumably food-borne. J Am Med Assoc. 1952;149(11):993-995.
66. Expert Committee on Hepatitis. First Report. TRS 62. Geneva, Switzerland: World Health Organization; 1953.
67. Stebbins EL. Jaundice IV. Distant appraisal of yellow fever vaccine hepatitis. Tex State J Med. 1951;47:146-148.
68. Seeff LB, Beebe GW, Hoofnagle JH, et al. A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med. 1987;316(16):965-970.
69. Feinstone SM, Kapikian AZ, Purcell RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science. 1973;182:1026-1028.
70. Provost PJ, Hilleman MR. Propagation of human hepatitis A virus in cell culture in vitro. Proc Soc Exp Biol Med. 1979;160:213-221.
71. Cohen JI, Ticehurst JR, Feinstone SM, Rosenblum B, Purcell RH. Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol. 1987; 61:3035-3039.
72. Martin A, Lemon SM. Hepatitis A virus: from discovery to vaccines. Hepatology. 2006;43:S164-S172.
73. Blumberg BS, Alter HJ, Visnich SA. A new antigen in leukemia serum. JAMA. 1965;191:541-546.
74. Blumberg BS, Gerstley BJS, Hungerford DA, London WT, Sutaik AJ. A serum antigen (Australian antigen) in Down's syndrome, leukaemia and hepatitis. Ann Intern Med. 1967;66:924-931.
75. Blumberg BS, Sutnick AI, London WT, Millman I. Australia antigen and hepatitis. A comprehensive review. CRC Crit Rev Clin Lab Sci. 1971;2:473-528.
76. Dane DS, Cameron CH, Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1970;1:695-698.
77. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P. Nucelotide sequence of the hepatitis B virus genome (subtype ayw) closed in E. coli. Nature. 1979;281:646-650.
78. Prince AM, Brotman B, Grady GF, et al. Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet. 1974;2:241-246.
79. Feinstone S, Kapikian AZ, Purcell RH, et al. Transfusion associated hepatitis not due to viral hepatitis type A or B. N Engl J Med. 1975;292:767-770.
80. Alter J, Purcell RH, Holland PV, et al. Transmissible agent in non-A, non-B hepatitis. Lancet. 1978;1:459-463.
81. Tabor E, Gerety RJ, Drucker JA, et al. Transmission of non-A, non-B hepatitis from man to chimpanzee. Lancet. 1978;1:463-466.
82. Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244: 359-362.
83. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989;244:362-364.
84. Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A. 1990;87:9524-9528.
85. Kato N. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity and variation. Microb Comp Genomics. 2000;5(3):129-151.
86. Seeff LB. The history of the "natural history" of hepatitis C (1968-2009). Liver Int. 2009;29(suppl 1):89-99.
87. Houghton M. The long and winding road leading to the identification of the hepatitis C virus. J Hepatol. 2009;51: 939-948.
88. Rizzetto M, Canese MG, Aricò S, et al. Immunofluorescence detection of a new antigen-antibody system (delta/anti-delta) associated with hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18:997-1003.
89. Rizzetto M, Hoyer B, Canese MG, Shih JWK, Purcell RH, Gerin JL. Delta antigen: the association of delta antigen with hepatitis B surface antigen and ribonucleic acid in the serum of delta infected chimpanzees. Proc Natl Acad Sci U S A. 1980;77:6124-6128.
90. Rizzetto M, Canese MG, Gerin JL, London WT, Sly LD, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis. 1980;141:590-602.
91. Rizzetto M. Hepatitis D: thirty years after. J Hepatol. 2009;50:1043-1050.
92. Wang KS, Choo QL, Weiner AJ, et al. Structure, sequence and expression of the hepatitis delta (delta) viral genome [erratum appears in Nature. 1987;328:456]. Nature. 1986;323:508-514.
93. Taylor JM. Structure and replication of hepatitis delta virus RNA. Curr Top Microbiol Immunol. 2006;307:1-23.
94. Khuroo MS. Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med. 1980;68:818-823.
95. Khuroo MS. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res. 2011;161(1):3-14.
96. Reyes GR, Purdy MA, Kim J, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990; 247:1335-1339.
97. Tam AW, Smith MM, Guerra ME, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 1991;185: 120-131.
98. Dienstag JL. Chapter 304: Acute viral hepatitis. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, eds. Harrison's Online. Featuring the Complete Contents of Harrison's Principles of Internal Medicine.18th ed. Access Medicine from McGraw-Hill. Available at: http://accessmedicine.com/ resourceTOC. aspx?resourceID=4. Accessed July 8, 2012.